LifexScience
Solving the 21st century's most profound challenges through the synergy of human purpose and rigorous evidence.
Fueling Purposeful Innovation through Purpose x People x Profit x Tech
The "Why"
Everything begins with Life. We define it as the preservation of humankind, the pursuit of longevity, and the enhancement of the human experience. Whether we are exploring advanced biotechnology or nutraceuticals, our compass is always pointed toward making life healthier, more resilient, and more meaningful.
The "How"
If Life is our purpose, Science is our methodology. We do not chase trends; we chase evidence. From AI-driven diagnostics to science-backed nutraceutical platforms, we use science as the tool to scale impactful technologies—rigorous, data-driven, and cutting edge.
More than investors — visionaries, problem-solvers, and enablers of groundbreaking technology.
Our team is united by a shared passion for scaling technologies at the intersection of life sciences and environmental resilience. Operating at the convergence of capital and execution, we bring multi-disciplinary expertise across corporate M&A, investment, and cross-border commercialization to serve as active co-builders. By anchoring global innovations to regional infrastructure, we build and scale high-impact platforms across Bio+Health and sustainable bio-resources. We work hand-in-hand with global innovators to accelerate their journey from concept to market impact.
What We Do | Our Operational Playbook
Commercialization & Market Entry
We partner with global innovators to navigate complex regional landscapes, unlock institutional pipelines, and drive cross-border commercial acceleration.
VENTURE CO-BUILDING
We bridge the gap between breakthrough science and commercial enterprise. Rather than acting as passive capital or transactional distributors, we co-build from the earliest stages—working hands-on to demonstrate proof of concept, establish commercial operations, and build co-owned ventures that scale shared value across Southeast Asia.
Investment
Identifying and funding cutting-edge technologies with the potential to revolutionize industries.
Three focus areas.
One formula.
We invest where Life and Science compound — backing founders whose technology is defensible, whose science is rigorous, and whose markets are ready to inflect.
Life = Bio + Health
Advanced biotechnology, medical devices, nutraceuticals, and longevity — evidence-based solutions that make human life healthier and more resilient.
AI-Enabled
AI-assisted healthcare, diagnostics that transform data into clinical and operational leverage across emerging markets.
Digital Consumer
Consumer platforms — funcational consumer products, proptech and digital services — engineered for scale and durable behavior change.
Portfolio
A selection of companies we back, commercialize, and scale across Southeast Asia and beyond.
QURE.ai
LHOOPA
HOMEBASE
FLOWMINGO.ai
EFISHERY (Exited)
FANSLINK (Exited)
Team
Pat Rujipol stands at the intersection of healthcare, technology, and sustainability. As the founder of Lifescience Ventures, his vision is rooted in a simple but powerful formula: Life x Science.
An investment professional turned operator, he brings a rare duality to the life sciences sector. Across a 15-year career that transitioned from Energy, Petrochemicals, and corporate M&A into Venture Capital and technology, he has mastered the art of leveraging both minds — combining the analytical discipline of an investor with the hands-on agility of an entrepreneur to navigate the Commercialization Lifecycle.
Today, Pat steers high-impact initiatives that leverage the unique biodiversity of Southeast Asia. His strategic focus spans clinical commercialization of Healthcare AI with leaders like Qure.ai, next-generation AgBio+Health tech tailored for functional consumers, and sustainable biofuels — turning the region's natural wealth into scalable, science-backed enterprises.